Securities code: 600671 securities abbreviation: St eye medicine Announcement No.: pro 2022-008 Hangzhou Tianmushan Pharmaceutical Enterprise Co.Ltd(600671)
Announcement of the resolution of the first extraordinary general meeting of shareholders in 2022
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents. Important content tips: whether there is a veto proposal at this meeting: none. The convening and attendance of the meeting
（1） Time of the general meeting of shareholders: February 11, 2022
（2） Venue of the general meeting of shareholders: meeting room (3), second floor, second floor, block B, Shanda Science Park, No. 19, Jugong Road, Binjiang District, Hangzhou, Zhejiang Province ordinary shareholders attending the meeting and preferred shareholders who have restored their voting rights and their shares:
1. Number of shareholders and proxies attending the meeting 7
2. The total number of voting shares held by shareholders attending the meeting (shares) is 55919088
3. The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares
Proportion of total copies (%) 45.9185
（4） Whether the voting method complies with the provisions of the company law and the articles of association, and the chairmanship of the general meeting. The meeting was proposed by the board of directors and presided over by Mr. Li Feng, vice chairman, and voted by open ballot. The meeting was conducted by a combination of on-site voting and online voting. The method of holding the meeting complies with the provisions of the company law and relevant national laws and regulations. （5） Attendance of the company’s directors, supervisors and Secretary of the board of directors 1. There were 9 incumbent directors of the company and 8 attended the meeting, including director Li Feng, directors Dang Guojun, song Zhengjun, Yu Jing and Liu Chunjie, and independent directors Zhao Xiang, Li Bin and Peiyang; 2. There are 3 supervisors in office and 2 present; Supervisor Cheng Hua attended the meeting on site, and Yu Jiangbin video attended the meeting; Supervisor Zhang Jun entrusted supervisor Chenghua to attend due to work reasons; 3. Ren Jiapeng, Acting Secretary of the board of directors, did not attend the meeting due to work reasons. Liu Bo, general manager of the company, Wang Peijun, Geng min and Weng Xiangyang, deputy general managers of the company, attended the meeting as nonvoting delegates; Securities affairs representative Chen Guoxun attended as a nonvoting delegate. 2、 Deliberation of the proposal deliberation of the proposal (I) non cumulative voting proposal 1. Title of the proposal: interim proposal on requesting the removal of Mr. Ren Jiapeng from the post of non independent director of the 11th board of directors
Result of deliberation: voting:
Types of shareholders agree against waiver
Proportion of votes proportion of votes (%) (%)
A shares 55847788 99.8724 71300 0.1276 0.0000
2. Proposal Name: interim proposal on adding Mr. Liu Bo as a non independent director of the 11th board of directors
Result of deliberation: voting:
Types of shareholders agree against waiver
Proportion of votes proportion of votes proportion of votes
（%） （%） （%）
A shares 55847788 99.8724 71300 0.1276 0.0000
3. Proposal Name: proposal on adding Ms. Zhang Yingjun as supervisor of the company
Result of deliberation: voting:
Types of shareholders agree against waiver
Proportion of votes proportion of votes proportion of votes
（%） （%） （%）
A shares 55847788 99.8724 71300 0.1276 0.0000
（2） Voting of less than 5% of shareholders involved in major issues
Name of the proposal: agree against abstention
No. of votes proportion of votes proportion of votes (%) (%)
1. About applying 4048328 98.2692 71300 1.7308 0.0000 to exempt Ren Jiapeng
Mr. Xi
Session of the board of directors
Position of independent director
Ad hoc discussion of business
“Case”
2 “on the request for 4048328 98.2692 71300 1.7308 0.0000 to add by election”
Mr. Bo is public
The 11th
The board of directors is not independent
Provisional appointment of legislative director
Time proposal
3. Review on the supplement of 4048328 98.2692 71300 1.7308 0.0000 Zhang Yingjun
Ms. for the company
Deliberative Supervisor
“Case”
（3） The relevant information on the voting of proposals shows that the extraordinary general meeting of shareholders should be considered in order of the proposals. The preconditions for the deliberation and approval of proposal 2 are as follows: proposal 1 is passed by more than 1 / 2 of the voting rights held by the shareholders (including shareholders’ agents) attending the extraordinary general meeting of shareholders; Moreover, proposal 2 was passed by more than 1 / 2 of the voting rights held by the shareholders (including shareholders’ agents) attending the extraordinary general meeting. Proposal 3 proposed at the general meeting is an ordinary resolution, and the proposal was passed by more than 1 / 2 of the voting rights held by the shareholders and shareholders’ agents attending the general meeting. 3、 Lawyer witness 1. Law firm witnessed by the shareholders’ meeting: Beijing JUNHE (Hangzhou) law firm lawyers: Lin Jie, Guo Qianling 2. Lawyer witness conclusion: the convening and convening procedures of the shareholders’ meeting comply with the provisions of the company law, the securities law and other relevant laws and administrative regulations, the rules of the shareholders’ meeting and the articles of association, The qualifications of the persons attending the shareholders’ meeting and the convener of the meeting are legal and valid, and the voting procedures and results of the shareholders’ meeting are legal and valid. 4、 List of documents for future reference 1. Resolutions of the general meeting of shareholders signed and confirmed by the attending directors and recorders and stamped with the seal of the general meeting of shareholders; 2. A legal opinion signed and sealed by the director of the witnessed law firm; 3. Other documents required by the exchange.
Hangzhou Tianmushan Pharmaceutical Enterprise Co.Ltd(600671)
February 12, 2021
